(PALM BEACH GARDENS, FL) February 5, 2019—Zimmer Biomet (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the expansion of its Dental product portfolio to include non-resorbable membranes and sutures. The new OsseoGuard® non-resorbable product line includes dense PTFE (Polytetrafluoroethylene) membranes in multiple texture variations, as well as a titanium mesh and PTFE sutures. OsseoGuard products are currently available in the US and Canada.
OsseoGuard membranes are specifically engineered to eliminate bacterial infiltration into the surgical site while preventing tissue from growing into the bone cavity. High-density PTFE used in the manufacturing process greatly reduces the membrane’s pore size to a submicron (less than 0.3 microns) level. OsseoGuard non-resorbable dental membranes are recommended in certain complex cases, such as vertical ridge augmentation procedures, where longer lasting and space-maintaining membranes are needed because resorbable products may resorb too quickly.
“Zimmer Biomet Dental is very excited to now provide advanced barrier membranes and sutures to our customers for ridge augmentation and other relevant procedures,” said Indraneel Kanaglekar, Vice President, Global Product Management and R&D. “As a market leader in dental regenerative solutions, it is important that we keep diversifying and growing our available solutions in order to address the specific needs and preferences of clinicians.”
OsseoGuard non-resorbable membranes are available in a variety of textured, smooth (non-textured), titanium reinforced and titanium mesh options, giving a clinician the choice of different handling, shapes, sizes and thicknesses. OsseoGuard sutures offer eight precision needle options. These new products supplement the already robust portfolio of resorbable membranes, which includes Puros® Pericardium, CopiOs® Pericardium, CopiOs Extend®, BioMend®, BioMend Extend™, OsseoGuard and OsseoGuard Flex®.
For more information on OsseoGuard Non-Resorbable Membranes and Sutures, or any of Zimmer Biomet Dental’s solutions for regenerative procedures, contact a Zimmer Biomet sales representative or visit www.zimmerbiometdental.com.
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
Cautionary Statement Regarding Forward-Looking Statements
This release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see Zimmer Biomet’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC. Forward-looking statements speak only as of the date made. Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this release.
(Palm Beach Gardens, FL) – May 19, 2017—Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the appointment of Pedro Malha to General Manager of its Dental division, headquartered in Palm Beach Gardens, Fla. As General Manager, he will lead the global strategy and operations for the Dental business, which provides surgical, restorative, regenerative and digital dentistry solutions, as well as industry leading continuing education to dental professionals worldwide. Malha will report directly to Adam Johnson, Group President of Zimmer Biomet Spine, Dental, CMF and Thoracic.
“Mr. Malha’s broad experience across multiple medical device specialties and geographies will bring unique perspective and insights to our global business,” said Johnson. “His leadership will be invaluable in defining the organization’s path forward as we continue to develop differentiated, high-quality solutions for our customers and their patients.”
Malha brings more than 20 years of experience in the healthcare segment, where he has a strong track record of building medical device and pharmaceutical brands, developing commercial capabilities and driving strong, profitable growth globally. Malha most recently served as head of the global strategic efforts for Abbott Vision Care. He has held leadership roles in various business units of Abbott, including Vice President for the EMEA Region and Head of North Europe for Abbott’s Diabetes Division. Prior to joining Abbott, Malha was a Strategy Consultant with Ernst & Young in New York City.
A graduate of Bentley University with a bachelor’s degree in management, Malha also holds a Master of Business Administration from Boston University.
"I am honored to be joining Zimmer Biomet,” Malha said. “I look forward to working with our employees and clinicians around the world and to building on the Company's leadership in service excellence, innovative technology, and product quality. Together, we will help our customers achieve better patient outcomes in their daily practice.”
All references to Zimmer Biomet Dental contained herein refer to the dental subsidiaries of Zimmer Biomet Holdings, Inc. ©2017 Zimmer Biomet. All rights reserved.
Leader in musculoskeletal healthcare will now distribute a fully synthetic bone graft delivered in a proprietary cartridge delivery system
(Palm Beach Gardens, FL) – April 12, 2017—Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the distribution of NovaBone Dental Putty through its dental division in over 40 countries within the Middle East, Africa, Latin America, Asia Pacific and select markets in Europe. NovaBone Dental Putty is manufactured by NovaBone Products, LLC. NovaBone is a fully synthetic bone graft engineered for enhanced handling and improved performance. In addition to being osteoconductive, the calcium phosphosilicate particles within the product’s formulation promote osteostimulation. NovaBone putty has over 20 years of clinical success documented by more than 50 peer-reviewed publications.1
NovaBone Dental Putty offers unique consistency, with no mixing or thawing required prior to placement.2 The putty adapts to the defect surface and allows uniform surface contact with the bony walls of the defect and eliminates over-condensation or undercondensation of the graft material.2 In addition, the product does not adhere to surgical gloves or instruments during manipulation. Precise, controlled application using a cartridge delivery system reduces waste and facilitates defect fill.
NovaBone Dental Putty is available in multiple delivery options, including pre-filled syringes and the cartridge delivery system with disposable, single-dose cartridges in .25 cc and .5 cc. The diameter of the cannula is 2.8 mm, which is ideal for dispensing the graft, especially in minimally invasive techniques such as gaps in immediate implant placement and crestal approach sinus lift procedures.
“Our new collaboration with NovaBone Products, LLC will enable us to provide new and advanced bone grafting solutions to our customers,” said Brett Deaver, Vice President, Global Marketing and Education, Zimmer Biomet Dental. “The unique osteoconductive and osteostimulatory properties of the synthetic material, and the variety of delivery options, set NovaBone Dental Putty apart in the industry. It also complements very well
our existing brands in the allograft and xenograft space.”
“NovaBone Products, LLC is very excited to partner with Zimmer Biomet Dental in a large number of dental markets. I have long believed that our technology and delivery systems will lead to great success,” said Art Wotiz, President of NovaBone Products, LLC. “Now, with the power of Zimmer Biomet Dental’s sales and marketing teams, I am confident of strong growth of the NovaBone brand. This new relationship is exclusive between NovaBone Products, LLC and Zimmer Biomet Dental. There is no relationship in place, or being considered, for the orthopaedic market.”
1. Data on file.
2. Kotsakis G, Chrepa V. Removal of a Large Radicular Cyst and Simultaneous Ridge Regeneration Utilizing Alloplastic Calcium Phosphosilicate Putty
in Combination with Platelet Rich Fibrin (PRF): A Case Report. Journal of Implant & Advanced Clinical Dentistry. 2012; 4(2): 41-47
All references to Zimmer Biomet Dental contained herein refer to the dental subsidiaries of Zimmer Biomet Holdings, Inc. Unless otherwise indicated,
as referenced herein, all trademarks are the property of Zimmer Biomet; and all products are manufactured, distributed and marketed by Zimmer
Biomet Dental (and, in the case of distribution and marketing, its authorized marketing partners). For additional product information, please refer to the
individual product labeling/IFU. Product clearance and availability may be limited to certain countries/regions. This material is intended for clinicians
only and does not comprise medical advice or recommendations. ©2017 Zimmer Biomet, All rights reserved.
Leader in musculoskeletal healthcare expands Tapered Screw-Vent® Family of dental implants featuring new coronal texturing options with microgrooves
(PALM BEACH GARDENS, FL) August 16, 2016—Zimmer Biomet (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, launches the TSVT and TSVM MP-1® HA Dental Implants, manufactured by Zimmer Dental. An extension of the successful1 Tapered Screw-Vent® Implant Family, these additional implant configurations are designed to address clinical challenges and preferences for crestal bone maintenance and soft tissue management through coronal texturing options with microgrooves.
TSVT and TSVM MP-1 HA Implants feature a highly crystalline MP-1 HA-coated midsection designed to resist dissolution for long-term coating stability, while achieving high levels of bone-to-implant contact.1 The TSVT and TSVM MP-1 HA Implants are available in the same diameters and lengths as existing TSV™ Implants. New configuration options include:
TSVT: MTX® microtexturing to the top of the implant, coronal microgrooves and an MP-1 HA-coated midsection
TSVM: 0.5mm machined collar, coronal microgrooves with the MTX Surface and an MP-1 HA- coated midsection
“We are excited to offer dental clinicians these contemporary options from Zimmer Biomet to expand their surgical repertoires. Importantly, the TSVT and TSVM MP-1 HA Implants offer the same primary stability, prosthetic stability and long-term clinical success that have been well documented over the past 15 years with the Tapered Screw-Vent Implant Family,” said David Josza, General Manager of Zimmer Biomet’s dental division. “As we continue to expand our dental offerings to address a broad range of clinical situations and surgeon preference, we will continue focusing on our customers with an innovative dental portfolio of implant and regenerative solutions, leading service and support capabilities and world-class medical education.”
TSVT and TSVM MP-1 HA Implants feature the exclusive Platform Plus™ Technology, which minimizes micromovement and screw-loosening for prosthetic stability and creates highly favorable conditions for long-term crestal bone maintenance:
Lead-in Bevel – Designed to reduce horizontal stresses better than flat “butt-joint” connections1
Friction-Fit Connection – Virtually eliminates abutment micromovement leading to screw loosening1
1.5mm Deep Internal Hex – Shields the abutment retention screw from excess loading, distributing occlusal forces deep into the implant1
All references contained herein to Zimmer Biomet Dental refer to the Zimmer Biomet Dental Division. Due to regulatory requirements, Zimmer Biomet’s dental division will continue to manufacture products under Zimmer Dental Inc. and Biomet 3i LLC respectively until further notice.
Training center focuses on strengthening and enhancing the dental profession by offering scientific educational courses to dental clinicians from around the world.
(PARSIPPANY, NJ) February 16, 2016–Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the grand re-opening of its dental division’s Zimmer Biomet Institute training center in Parsippany, New Jersey. The Zimmer Biomet Institute Parsippany training center is a part of the dental division of Zimmer Biomet.
The newly enhanced 20,000 square foot dental training center includes a simulation lab, a cadaver lab and lecture room. The facility dedicated to training provides scientific educational courses for dental clinicians from around the world who are interested in restorative, surgical and regenerative procedures. The courses offered at the center include cadaveric-based training, case study reviews and simulation workshops (on lifelike mannequins) in our proprietary, state-of-the-art patient training laboratory. This provides optimal hands-on experience and support to clinicians as they strive to refine their clinical skills.
Focusing on strengthening and enhancing the dental profession through education, the Zimmer Biomet Institutes in North America train more than 1,000 dental clinicians through 65+ courses offered annually.
“We are thrilled to re-open our doors as the Zimmer Biomet Institute and excited to build on the foundation of our ability to provide dynamic professional training,” said Ken Varner, the Director of Institutes for Zimmer Biomet’s dental division. “During our re-opening in Parsippany on February 10, clinicians were able to see first-hand the best in class dental training offerings available in our new facility.”
In order to meet the growing demand from clinicians and the expanding global business of dental implantology, additional facilities will open in China in late 2016 and Palm Beach Gardens, Florida in late 2017. The Carlsbad, California facility will be moving to an enhanced site in June 2016. Existing facilities operate in Bogota, Columbia and Winterthur, Switzerland.
(Palm Beach Gardens, FL) – February 19, 2016 – The Zimmer Biomet dental division is pleased to announce the U.S. launch of its new 3i T3 Short Implants, manufactured by Biomet 3i. The company is also offering a comprehensive new surgical kit designed specifically to support site preparation and placement of 3i T3 Short Implants. The 3i T3 Short Implants have been commercially available in Europe and Australia since June of 2015. Dr. Francesco Amato stated, “The 3i T3 Short Implant provides me with an implant treatment option for patients with limited bone height, reducing the need for a sinus elevation or vertical ridge augmentation procedure.”
The 3i T3 Short Implants are available in 5 and 6mm diameters with 5 and 6mm lengths and provide a familiar surgical protocol without the need for vertical grafting procedures in some challenging clinical cases. They feature the 3i T3 Surface along the full length of the implant, increased implant/abutment clamping force when using the Gold-Tite® Screw, and instrumentation designed to create a tight implant-to-osteotomy fit, which assists with primary stability. In addition, the system includes new instruments designed specifically for the 3i T3 Short Implants, such as the Flat-bottom Shaping Drills that match the dimensions of the implant and provide a countersink.
A Strong, Esthetic Solution for Narrow Anterior Spaces
(Palm Beach Gardens, FL) – February 16, 2016–Zimmer Biomet’s dental division is pleased to announce the availability of its new 3.1 mmD Eztetic™ Implant, manufactured by Zimmer Dental, and accompanying surgical and restorative components. The 3.1mmD Eztetic Implant offers a strong, esthetic solution for narrow anterior sites.
“Zimmer Biomet’s dental division takes pride in developing high-quality products based upon solid research and feedback from our customers. We had a vision to create a narrow, strong anterior solution with high primary stability which will enable clinicians to perform immediate restorations, when appropriate, in the esthetic zone. We are pleased that the 3.1mmD Eztetic Implant achieves this vision with a balance of features designed for strength and beauty in the anterior,” said Michael Collins, who served as the Zimmer Dental Vice President of R & D during the implant’s development.
Exceptional Strength & Primary Stability
The 3.1mmD Eztetic Implant is designed to offer improvements over similar commercially available implants, particularly in the areas of strength and primary stability. When compared to select competitive implants of similar diameters, the Eztetic Implant achieved a 43% higher fatigue strength.1 In addition, the implant performed exceptionally well in insertion torque and torsional yield strength testing.1
Three Principles Combined to Create One State-of-the-Art Connection
For the first time, three concepts have been combined to create a precise implant-abutment connection designed to reduce micromovement and microleakage. This unique connection consists of a conical interface, platform switch and Double Friction-Fit™ technology designed to make strong narrow-diameter implants indicated for all anterior areas.
Designed for Superior Esthetic Outcomes
The Eztetic implant-abutment connection, along with a Contour Abutment profile, is designed to provide space for soft tissue and esthetic emergence of the restoration.
In addition, a wide range of user-friendly restorative options are available, including abutments for cement-retained, custom, and overdenture restoration, aiming to give clinicians the ability to perform quality esthetic restorations with confidence and ease.
The Zimmer Biomet dental division represents the joined forces of Zimmer Dental and BIOMET 3i and is a leader in oral health care solutions.
1 Data on file
Be first to know about latest news and exclusive offers SUBSCRIBE